However, further investigations of ILC infiltration in bladder tissues from spontaneous bladder tumor model and bladder cancer patients, with the assessment of effector cytokine secretion and activation or exhaustion markers, are warranted to clarify the involvement of ILC subsets in bladder cancer, including over the BCG treatment course. The gene discussed is CCL27; the disease is urinary bladder cancer.